124 related articles for article (PubMed ID: 3122114)
1. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
Coles GA; Alobaidi HM; Topley N; Davies M
Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
[TBL] [Abstract][Full Text] [Related]
2. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
[TBL] [Abstract][Full Text] [Related]
3. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
Keane WF; Comty CM; Verbrugh HA; Peterson PK
Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
[TBL] [Abstract][Full Text] [Related]
4. Opsonic requirements of Staphylococcus epidermidis.
Clark LA; Easmon CS
J Med Microbiol; 1986 Aug; 22(1):1-7. PubMed ID: 3735386
[TBL] [Abstract][Full Text] [Related]
5. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis.
Clark LA; Easmon CS
J Clin Pathol; 1986 Aug; 39(8):856-60. PubMed ID: 3745476
[TBL] [Abstract][Full Text] [Related]
6. Peritonitis prevention in CAPD.
Carozzi S; Lamperi S
Clin Nephrol; 1988; 30 Suppl 1():S45-8. PubMed ID: 3141093
[TBL] [Abstract][Full Text] [Related]
7. Strain differences in the opsonisation of Staphylococcus epidermidis.
Bennett-Jones DN; Yewdall VM; Gillespie CM; Ogg CS; Cameron JS
Perit Dial Int; 1989; 9(4):333-9. PubMed ID: 2488390
[TBL] [Abstract][Full Text] [Related]
8. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
[TBL] [Abstract][Full Text] [Related]
9. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
[TBL] [Abstract][Full Text] [Related]
10. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
Gordon DL; Rice JL; Avery VM
Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
[TBL] [Abstract][Full Text] [Related]
11. Does the response to hepatitis B vaccination predict CAPD-associated infections?
Holley JL
Adv Perit Dial; 1996; 12():218-20. PubMed ID: 8865907
[TBL] [Abstract][Full Text] [Related]
12. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J
Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
[TBL] [Abstract][Full Text] [Related]
13. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
Håkansson L; Hällgren R; Venge P
Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
Davies SJ; Yewdall VM; Ogg CS; Cameron JS
Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
[TBL] [Abstract][Full Text] [Related]
15. Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial.
Poole-Warren LA; Hallett MD; Hone PW; Burden SH; Farrell PC
Clin Nephrol; 1991 May; 35(5):198-206. PubMed ID: 1855327
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses and opsonic activity in sera of preterm neonates with coagulase-negative staphylococcal septicemia and the effect of the administration of fresh frozen plasma.
Krediet TG; Beurskens FJ; van Dijk H; Gerards LJ; Fleer A
Pediatr Res; 1998 May; 43(5):645-51. PubMed ID: 9585011
[TBL] [Abstract][Full Text] [Related]
17. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
[TBL] [Abstract][Full Text] [Related]
18. Persistence of positive dialysate cultures after apparent cure of CAPD peritonitis.
Tzamaloukas AH; Hartshorne MF; Gibel LJ; Murata GH
Adv Perit Dial; 1993; 9():198-201. PubMed ID: 8105923
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
[TBL] [Abstract][Full Text] [Related]
20. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
